Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-23.21	87.69	114.20
Graham Fair Price	7.70	18.03	16.74
PEG	-42.29	2.14	-3.71
Price/Book	-16.58	15.12	18.13
Price/Cash Flow	29.72	168.12	129.60
Prices/Earnings	-25.99	31.93	43.14
Price/Sales	-14.67	34.93	40.94
Price/FCF	29.72	168.12	129.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	5.38	0.69	0.65
Operating Margin	14.16	0.37	0.32
ROA	13.60	0.04	0.04
ROE	0.11	0.12	12.72
ROIC	0.05	0.06	12.28
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-43.59
Dividends QOQ	< 0.005	0.15	5083.93
EBIT QOQ	-0.15	0.13	-14.58
EPS QOQ	-0.12	0.15	28.25
FCF QOQ	0.21	-0.35	68.43
Revenue QOQ	0.03	-0.01	-63.94
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	301.65	350.87	16.32
Days Sales Outstanding (DSO)	53.03	53.14	0.20
Inventory Turnover	0.30	0.26	-14.03
Debt/Capitalization	0.57	0.57	-0.71
Quick Ratio	1.77	1.71	-3.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	10.89	11.04	1.44
Cash	4.45	4.31	-3.02
Capex	-0.43	-0.31	29.14
Free Cash Flow	1.52	0.99	-34.76
Revenue	4.82	4.78	-0.82
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.36	3.33	-0.80
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.70	5.17	-9.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating